rs2229519

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000158.4(GBE1):​c.568A>G​(p.Arg190Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.305 in 1,571,242 control chromosomes in the GnomAD database, including 75,472 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 6997 hom., cov: 32)
Exomes 𝑓: 0.31 ( 68475 hom. )

Consequence

GBE1
NM_000158.4 missense

Scores

1
7
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:19

Conservation

PhyloP100: 3.51

Publications

44 publications found
Variant links:
Genes affected
GBE1 (HGNC:4180): (1,4-alpha-glucan branching enzyme 1) The protein encoded by this gene is a glycogen branching enzyme that catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on the same or a neighboring glycogen chain. Branching of the chains is essential to increase the solubility of the glycogen molecule and, consequently, in reducing the osmotic pressure within cells. Highest level of this enzyme are found in liver and muscle. Mutations in this gene are associated with glycogen storage disease IV (also known as Andersen's disease). [provided by RefSeq, Jul 2008]
GBE1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to glycogen branching enzyme deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
  • adult polyglucosan body disease
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002937764).
BP6
Variant 3-81648979-T-C is Benign according to our data. Variant chr3-81648979-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 197636.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.429 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000158.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBE1
NM_000158.4
MANE Select
c.568A>Gp.Arg190Gly
missense
Exon 5 of 16NP_000149.4Q04446

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBE1
ENST00000429644.7
TSL:1 MANE Select
c.568A>Gp.Arg190Gly
missense
Exon 5 of 16ENSP00000410833.2Q04446
GBE1
ENST00000895874.1
c.568A>Gp.Arg190Gly
missense
Exon 5 of 16ENSP00000565933.1
GBE1
ENST00000942742.1
c.562A>Gp.Arg188Gly
missense
Exon 5 of 16ENSP00000612801.1

Frequencies

GnomAD3 genomes
AF:
0.299
AC:
45374
AN:
151906
Hom.:
6994
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.274
Gnomad AMI
AF:
0.198
Gnomad AMR
AF:
0.259
Gnomad ASJ
AF:
0.206
Gnomad EAS
AF:
0.445
Gnomad SAS
AF:
0.310
Gnomad FIN
AF:
0.402
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.270
GnomAD2 exomes
AF:
0.317
AC:
70584
AN:
222350
AF XY:
0.316
show subpopulations
Gnomad AFR exome
AF:
0.278
Gnomad AMR exome
AF:
0.295
Gnomad ASJ exome
AF:
0.211
Gnomad EAS exome
AF:
0.452
Gnomad FIN exome
AF:
0.412
Gnomad NFE exome
AF:
0.305
Gnomad OTH exome
AF:
0.300
GnomAD4 exome
AF:
0.306
AC:
434420
AN:
1419218
Hom.:
68475
Cov.:
27
AF XY:
0.305
AC XY:
215363
AN XY:
705024
show subpopulations
African (AFR)
AF:
0.275
AC:
8798
AN:
31946
American (AMR)
AF:
0.292
AC:
12046
AN:
41306
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
5287
AN:
25606
East Asian (EAS)
AF:
0.432
AC:
16756
AN:
38784
South Asian (SAS)
AF:
0.296
AC:
23806
AN:
80334
European-Finnish (FIN)
AF:
0.414
AC:
21522
AN:
52018
Middle Eastern (MID)
AF:
0.210
AC:
1196
AN:
5690
European-Non Finnish (NFE)
AF:
0.302
AC:
327313
AN:
1084656
Other (OTH)
AF:
0.301
AC:
17696
AN:
58878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
11814
23628
35443
47257
59071
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10750
21500
32250
43000
53750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.299
AC:
45395
AN:
152024
Hom.:
6997
Cov.:
32
AF XY:
0.303
AC XY:
22480
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.274
AC:
11370
AN:
41500
American (AMR)
AF:
0.259
AC:
3960
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
715
AN:
3468
East Asian (EAS)
AF:
0.444
AC:
2298
AN:
5174
South Asian (SAS)
AF:
0.311
AC:
1500
AN:
4818
European-Finnish (FIN)
AF:
0.402
AC:
4244
AN:
10552
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.302
AC:
20489
AN:
67904
Other (OTH)
AF:
0.271
AC:
572
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1622
3243
4865
6486
8108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
466
932
1398
1864
2330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.299
Hom.:
28517
Bravo
AF:
0.290
TwinsUK
AF:
0.309
AC:
1144
ALSPAC
AF:
0.304
AC:
1170
ESP6500AA
AF:
0.277
AC:
992
ESP6500EA
AF:
0.301
AC:
2441
ExAC
AF:
0.306
AC:
36856
Asia WGS
AF:
0.391
AC:
1360
AN:
3472

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
5
Glycogen storage disease, type IV (5)
-
-
3
Adult polyglucosan body disease (3)
-
-
2
not provided (2)
-
-
1
Glycogen storage disease, type IV;C1856301:Glycogen storage disease IV, classic hepatic (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.71
D
Eigen
Benign
0.18
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.79
T
MetaRNN
Benign
0.0029
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
3.5
PrimateAI
Benign
0.28
T
PROVEAN
Pathogenic
-4.5
D
REVEL
Uncertain
0.32
Sift
Uncertain
0.020
D
Sift4G
Benign
0.066
T
Polyphen
0.013
B
Vest4
0.089
MPC
0.041
ClinPred
0.056
T
GERP RS
4.8
Varity_R
0.37
gMVP
0.68
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229519; hg19: chr3-81698130; COSMIC: COSV70097964; API